A Screening Study on Dermatoses in Pregnancy

    January 2017 in “ Journal of Clinical and Diagnostic Research ”
    K Kannambal, GK Tharini
    Image of study
    TLDR Most pregnant women experience skin changes, mainly increased pigmentation, and some develop pregnancy-related skin conditions and infections.
    In a 2017 study involving 500 pregnant women, 94.8% experienced physiological skin changes, predominantly pigmentary changes (90.8%). Specific dermatoses of pregnancy were observed in 14% of participants, with pruritus gravidarum being the most common (10.4%). Infections were found in 30.8% of the women, with fungal infections accounting for 23.8%. The study highlighted that skin changes are mostly physiological during pregnancy, but attention is needed for potential dermatological diseases and infections. Specific dermatoses were more frequent in first-time pregnancies and in the third trimester. Conditions like neurofibromatosis and systemic lupus erythematosus were also noted to exacerbate during pregnancy. The study's findings may be overrepresented due to the tertiary health care setting in which it was conducted.
    Discuss this study in the Community →

    Research cited in this study

    3 / 3 results

    Related Community Posts Join

    5 / 5 results

      community Don’t Get Too Hyped About PP405. We've Seen This Movie Before.

      in Research/Science  203 upvotes 1 week ago
      PP405 is a new hair loss treatment showing early promise with a 20% hair density increase, but skepticism exists due to past failures of similar treatments like Pyrilutamide, RU58841, and Bimatoprost. Users debate its potential effectiveness, with some hopeful due to Google's involvement, while others urge caution without more evidence.
      If You Have DUPA, PLEASE READ THIS: Everyone Should Be Scalp Biopsied

      community If You Have DUPA, PLEASE READ THIS: Everyone Should Be Scalp Biopsied

      in Research  830 upvotes 10 months ago
      Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

      community Topical finasteride now the safest possible path?

      in Finasteride/Dutasteride  84 upvotes 11 months ago
      Topical finasteride is considered a safer option for hair regrowth with fewer systemic side effects compared to oral finasteride. Some users report similar efficacy and side effects between topical and oral treatments, while others prefer topical due to reduced systemic exposure.

      community Kintor Phase 2 Results released KX-826 (pyrilutamide)

      in Research/Science  447 upvotes 2 years ago
      Kintor Pharmaceutical's Phase 2 results with the drug Pyrilutamide, a potential alternative to 5-ARI drugs like Finasteride and Dutasteride but without the side effects. It could be used in combination with other topical treatments such as Minoxidil. The safety of the drug has been demonstrated in 6 months of use, however there are still questions about long term efficacy and systemic absorption.

    Similar Research

    5 / 1000+ results